-
公开(公告)号:US20230321230A1
公开(公告)日:2023-10-12
申请号:US18190068
申请日:2023-03-24
发明人: Bowen Li , Allen Jiang , Robert S. Langer , Daniel G. Anderson
IPC分类号: A61K39/215 , C07K14/47 , A61K39/39 , C07K14/005
CPC分类号: A61K39/39 , A61K39/215 , C07K14/005 , C07K14/472 , A61K2039/53
摘要: Provided herein are, in various embodiments, methods and compositions comprising polynucleotides (e.g., mRNA) for eliciting an immune response. In certain embodiments, the disclosure provides for methods and compositions for enhancing efficacy of infectious disease treatment (e.g., mRNA vaccines). In still further embodiments, the disclosure provides methods and compositions for enhancing one or more vaccines, such as SARS-CoV-2 mRNA vaccines.
-
公开(公告)号:US20230183168A1
公开(公告)日:2023-06-15
申请号:US18080299
申请日:2022-12-13
IPC分类号: C07C237/16 , C07D211/86 , C07D211/82 , C07D207/12 , C07D207/09 , C07D231/12
CPC分类号: C07C237/16 , C07D211/86 , C07D211/82 , C07D207/12 , C07D207/09 , C07D231/12
摘要: Provided herein are compounds, such as compounds of Formula (I), and pharmaceutically acceptable salts, hydrates, solvates, polymorphs, co-crystals, tautomers, stereoisomers, and isotopically labeled derivatives thereof, and compositions, methods, uses, and kits thereof. The compounds provided herein are lipids useful for delivery of polynucleotides, such as mRNA, for the treatment and/or prevention of various diseases and conditions (e.g., genetic disease, proliferative disease, hematological disease, neurological disease, liver disease, spleen disease, lung disease, painful condition, psychiatric disorder, musculoskeletal disease, a metabolic disorder, inflammatory disease, or autoimmune disease).
-